These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z, Armaly Z, Nakhoul F, Hoffman A. Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [Abstract] [Full Text] [Related]
9. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T. Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019 [Abstract] [Full Text] [Related]